Clarivate PLC: management transactions · United States · SEC (Form 4)

About Clarivate PLC

Clarivate Plc (NYSE: CLVT) is a global business services, data and workflow software company with a U.S.-listed security traded on the NYSE and an operating footprint that spans multiple regions. From an international equity perspective, Clarivate should be viewed less as a traditional software vendor and more as a provider of mission-critical “transformative intelligence” built on proprietary datasets, analytics and expert services. The company serves three core end markets: Academia & Government, Intellectual Property, and Life Sciences & Healthcare. Clarivate’s current corporate structure dates to 2016, when the business emerged from the separation of Thomson Reuters assets, and the company was later incorporated in 2019 under Jersey law. Its functional headquarters are in London, while its market listing is in the United States on the NYSE under the ticker CLVT. Clarivate highlights a global workforce of more than 12,000 experts across 40+ countries and more than 45,000 customers in 180+ countries, underscoring the international scale of its franchise. ([clarivate.com](https://clarivate.com/about-us/?utm_source=openai)) Clarivate’s portfolio is organized around enriched data, insights and analytics, workflow solutions, and expert services. Its best-known assets include Web of Science, a leading citation and research intelligence platform used by universities and research institutions; Derwent, a highly regarded patent-search and patent-analytics solution; CompuMark, which supports trademark screening, watching and lifecycle management; and Cortellis, which provides intelligence for pharmaceutical and broader life sciences decision-making. The acquisition of ProQuest expanded Clarivate’s reach into academic libraries, scholarly content and research workflows, broadening the company’s relevance across institutions and researchers. These products are deeply embedded in client workflows, which helps support recurring revenue characteristics and customer retention. ([clarivate.com](https://clarivate.com/products/scientific-and-academic-research/research-discovery-and-workflow-solutions/webofscience-platform/web-of-science-core-collection/?utm_source=openai)) On a competitive basis, Clarivate operates in specialized markets with meaningful barriers to entry: trusted data quality, long historical datasets, brand credibility and high switching costs. In academic research, it competes on the depth and trustworthiness of its citation and discovery tools; in intellectual property, it supports law firms and corporate IP teams; and in life sciences, it helps customers identify opportunities, manage evidence and accelerate commercialization. Its geographic presence is global, with customers and operating resources distributed across the Americas, EMEA and Asia-Pacific, reducing reliance on any single country or region. ([clarivate.com](https://clarivate.com/about-us/?utm_source=openai)) Recent developments show that Clarivate is continuing to reposition the platform toward higher-value analytics and AI-enabled products. In 2025 and 2026, the company issued quarterly results and launched several initiatives, including Web of Science Research Intelligence and Nexus Connect, while also promoting new medtech insights. This points to an ongoing product refresh focused on institutional research, decision support and AI-enabled workflows. For investors, CLVT combines globally diversified recurring revenue streams with a portfolio of entrenched brands, but execution remains important, especially in converting product innovation into sustainable growth and margin improvement. ([clarivate.com](https://clarivate.com/news/clarivate-reports-first-quarter-2026-results/?utm_source=openai))